Results 231 to 240 of about 154,358 (318)
Abstract Background Sodium glucose cotransporter 2 inhibitors (SGLT2i) represent one of the four pillars of heart failure (HF) pharmacological therapy. Objective The study aims to clarify SGLT2i antiarrhythmic effect on patients with HF with reduced ejection fraction (HFrEF) in terms of atrial and ventricular arrhythmias (AAs and VAs) reduction ...
Marco Valerio Mariani+17 more
wiley +1 more source
Abstract Aims Cardiogenic shock (CS) is the deadliest manifestation of acute heart failure, with persistently high mortality rates and a lack of recent therapeutic breakthroughs. Accurate risk prediction is crucial in clinical decision‐making and the design of future clinical trials.
Elina Hynninen+14 more
wiley +1 more source
Halothane-Epinephrine-induced Cardiac Arrhythmias and the Role of Heart Rate [PDF]
J Zink+2 more
openalex +1 more source
The Importance of Cardiac Magnetic Resonance in the Assessment Risk of Cardiac Arrhythmias in Patients with Arterial Hypertension. [PDF]
Wysocki A+5 more
europepmc +1 more source
Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL.
Matteo Pagnesi+21 more
wiley +1 more source
Cardiac Arrhythmias during Halothane Anesthesia
P. E. VANIK, Hamilton S. Davis
openalex +1 more source
Glossopharyngeal neuralgia with cardiac arrhythmia: a rare but treatable cause of syncope. [PDF]
Roni Jacobson, R W Russell
openalex +1 more source
Cardiac arrhythmias of BCR-ABL inhibitors with or without triazole antifungal agents: A real-world pharmacovigilance study based on the food and drug administration adverse event reporting system database. [PDF]
Xie P+5 more
europepmc +1 more source
Abstract Aims To analyse the predictive value of advanced markers of right ventricular (RV) function and RV‐pulmonary arterial (PA) coupling in forecasting long‐term left ventricular (LV) improvement in de novo heart failure with reduced ejection fraction (HFrEF).
Aiste Monika Jakstaite+10 more
wiley +1 more source
Abstract Aims A novel marker left atrioventricular coupling index (LACI) has been proved to be associated with cardiovascular events in patients without history of cardiovascular disease. However, the studies on cardiac magnetic resonance‐derived LACI in hypertrophic cardiomyopathy (HCM) patients are limited, and the prognostic value of LACI has still ...
Jinyang Wen+10 more
wiley +1 more source